There results suggest that hypoxia-NOTCH1-SOX2 signaling axis is an important for maintaining CSCs in ovarian cancer, which may provide a novel opportunity for development of drugs to eliminate CSCs in ovarian cancer patients. Here, SOX2 is linked to ovarian carcinoma.